"Учреждение здравоохранения по показаниям оказывает экстренную, плановую и консультативную медицинскую помощь больным терапевтического, неврологического и хирургического профилей на бесплатной основе, включая выполнение коронароангиографии и стентирования при остром коронарном синдроме, выполнение кардиохирургических вмешательств. Минский научно-практический центр является головным учреждением в Республике Беларусь по проблемам трансплантологии и гематологии."

During the past decade, Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Kowa Research Institute, Inc." with 2 trials sponsored, "CTI BioPharma" with 1 trials sponsored, "Kartos Therapeutics, Inc." with 1 trials sponsored and "Polpharma Biologics S.A." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology" #1 collaborator was "Osmotica Pharmaceutical US LLC" with 1 trials as a collaborator and "PSI CRO" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology" are "Severe Hypertriglyceridemia" (2 trials), "Arthritis, Psoriatic" (1 trials), "Crohn's Disease" (1 trials), "Multiple Sclerosis" (1 trials) and "Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF)" (1 trials). Many other conditions were trialed in "Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology" in a lesser frequency.

Most popular intervention types in "Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Fenofibrate" (2 trials), "Guselkumab" (2 trials), "K-877" (2 trials) and "Placebo (for K-877)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Minsk Scientific and Practical Center of Surgery, Transplantology and Hematology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".